For the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.^1,2TAKE A LOOK AT
WHAT TYVASO CAN DO

Demonstrated Efficacy^1,3,4

DIRECT-TO-LUNG DELIVERY¹

ON-THE-GO DOSING

Discover TYVASO DPI, a simple-to-use, on-the-go device option.

LEARN MORE

Co-pay Assistance Program

PER CO-PAY

United Therapeutics offers a Co-Pay Assistance Program for eligible patients.

Learn More

DPI=dry powder inhaler.

References: 1. TYVASO DPI [package insert]. Research Triangle Park, NC: United Therapeutics Corporation; 2022. 2. Spikes LA, Bajwa AA, Burger CD, et al. BREEZE: open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI^™ in patients with pulmonary arterial hypertension. Pulm Circ. 2022;12:e12063. doi:10.1002/pul2.12063.

For the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.^1,2TAKE A LOOK AT
WHAT TYVASO CAN DO

Demonstrated Efficacy^1,3,4

SEE THE DATA

DIRECT-TO-LUNG DELIVERY¹

LEARN HOW IT WORKS

ON-THE-GO DOSING

DISCOVER HOW

Discover TYVASO DPI, a simple-to-use, on-the-go device option.

Co-pay Assistance Program

United Therapeutics offers a Co-Pay Assistance Program for eligible patients.

For the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.1,2TAKE A LOOK AT WHAT TYVASO CAN DO

Demonstrated Efficacy1,3,4

SEE THE DATA

DIRECT-TO-LUNG DELIVERY1

LEARN HOW IT WORKS

ON-THE-GO DOSING

DISCOVER HOW

Discover TYVASO DPI, a simple-to-use, on-the-go device option.

Co-pay Assistance Program

United Therapeutics offers a Co-Pay Assistance Program for eligible patients.

For the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.^1,2TAKE A LOOK AT
WHAT TYVASO CAN DO

Demonstrated Efficacy^1,3,4

DIRECT-TO-LUNG DELIVERY¹